C5aR a Novel Immunomodulator of Metabolic Signalling and Energy Metabolism in Skeletal Muscle

Project Details

StatusActive
Effective start/end date4/11/1925/02/23

Funding

  • Diabetes UK (18/0005875): £274,686.00